Literature DB >> 12954766

Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani.

Tanushri Sengupta1, Mandira Mukherjee, Chhabinath Mandal, Aditi Das, Hemanta K Majumder.   

Abstract

The amino acid sequences of the C-terminal domain (CTD) of the type II DNA topoisomerases are divergent and species specific as compared with the highly conserved N-terminal and central domains. A set of C-terminal deletion mutants of Leishmania donovani topoisomerase II was constructed. Removal of more than 178 amino acids out of 1236 amino acid residues from the C-terminus inactivates the enzyme, whereas removal of 118 amino acids or less has no apparent effect on the ability of the parasite enzyme to complement a temperature-sensitive mutation of the Saccharomyces cerevisiae topoisomerase II gene. Deletion analysis revealed a potent nuclear localization signal (NLS) within the amino acid residues 998-1058. Immunomicroscopy results suggest that the removal of an NLS in the CTD is likely to contribute to the physiological dysfunction of these proteins. Modeling of the LdTOP2 based on the crystal structure of the yeast type II DNA topoisomerase showed that the parasite protein assumes a structure similar to its yeast counterpart harboring all the conserved residues in a structurally similar position. However, a marked difference in electrostatic potential was found in a span of 60 amino acid residues (998-1058), which also do not have any homology with topoisomerase II sequences. Such significant differences can be exploited by the structure-based design of selective inhibitors using the structure of the Leishmania enzyme as a template.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954766      PMCID: PMC203312          DOI: 10.1093/nar/gkg727

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  55 in total

Review 1.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  Cellular roles of DNA topoisomerases: a molecular perspective.

Authors:  James C Wang
Journal:  Nat Rev Mol Cell Biol       Date:  2002-06       Impact factor: 94.444

Review 3.  Protozomics: trypanosomatid parasite genetics comes of age.

Authors:  Stephen M Beverley
Journal:  Nat Rev Genet       Date:  2003-01       Impact factor: 53.242

4.  Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.

Authors:  A Das; A Dasgupta; S Sharma; M Ghosh; T Sengupta; S Bandopadhyay; H K Majumder
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

5.  Structure and mechanism of DNA topoisomerase II.

Authors:  J M Berger; S J Gamblin; S C Harrison; J C Wang
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

6.  Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.

Authors:  B Mittra; A Saha; A R Chowdhury; C Pal; S Mandal; S Mukhopadhyay; S Bandyopadhyay; H K Majumder
Journal:  Mol Med       Date:  2000-06       Impact factor: 6.354

7.  A novel active DNA topoisomerase I in Leishmania donovani.

Authors:  Héctor Villa; Ana R Otero Marcos; Rosa M Reguera; Rafael Balaña-Fouce; Carlos García-Estrada; Yolanda Pérez-Pertejo; Babu L Tekwani; Peter J Myler; Kenneth D Stuart; Mary-Ann Bjornsti; David Ordóñez
Journal:  J Biol Chem       Date:  2002-11-19       Impact factor: 5.157

8.  Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy.

Authors:  Arnab Roy Chowdhury; Suparna Mandal; Anindya Goswami; Monidipa Ghosh; Labanya Mandal; Debabani Chakraborty; Agneyo Ganguly; Gayatri Tripathi; Sibabrata Mukhopadhyay; Santu Bandyopadhyay; Hemanta K Majumder
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

Review 9.  Culprit and victim -- DNA topoisomerase II.

Authors:  Udo Kellner; Maxwell Sehested; Peter B Jensen; Frank Gieseler; Pierre Rudolph
Journal:  Lancet Oncol       Date:  2002-04       Impact factor: 41.316

10.  During both interphase and mitosis, DNA topoisomerase II interacts with DNA as well as RNA through the protein's C-terminal domain.

Authors:  R Rzepecki; P A Fisher
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  9 in total

1.  Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.

Authors:  Jennifer S Dickey; Neil Osheroff
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

Review 2.  In front of and behind the replication fork: bacterial type IIA topoisomerases.

Authors:  Claudia Sissi; Manlio Palumbo
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

3.  Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Aditi Das; Chhabinath Mandal; Rakhee Das; Tanmoy Mukherjee; Hemanta K Majumder
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

4.  Centromere-associated topoisomerase activity in bloodstream form Trypanosoma brucei.

Authors:  Samson O Obado; Christopher Bot; Maria C Echeverry; Julio C Bayona; Vanina E Alvarez; Martin C Taylor; John M Kelly
Journal:  Nucleic Acids Res       Date:  2010-09-22       Impact factor: 16.971

5.  mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity.

Authors:  Kathryn L Gilroy; Chrysoula Leontiou; Kay Padget; Jeremy H Lakey; Caroline A Austin
Journal:  Nucleic Acids Res       Date:  2006-03-20       Impact factor: 16.971

6.  Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Rakhee Das; Aditi Das; Hemanta K Majumder
Journal:  Nucleic Acids Res       Date:  2005-04-28       Impact factor: 16.971

7.  Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB.

Authors:  Christopher F Prada; Raquel Álvarez-Velilla; Rosario Díaz-Gozález; Yolanda Pérez-Pertejo; Rafael Balaña-Fouce; Rosa M Reguera
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

8.  Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response.

Authors:  Amartya Mishra; Jayaraman Vinayagam; Sourav Saha; Sayan Chowdhury; Somenath Roy Chowdhury; Parasuraman Jaisankar; Hemanta K Majumder
Journal:  Pharmacol Res Perspect       Date:  2014-08-24

Review 9.  Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.

Authors:  Rafael Balaña-Fouce; Raquel Alvarez-Velilla; Christopher Fernández-Prada; Carlos García-Estrada; Rosa M Reguera
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-24       Impact factor: 4.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.